BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8195841)

  • 1. Pharmacokinetics of brodimoprim in special populations.
    Stockis A; Borzio F; Deroubaix X; Gaspari F; Jeanbaptiste B; Lebacq E; Lins R; Pavesio D; Pelozi GC; Rosillon D
    J Chemother; 1993 Dec; 5(6):480-7. PubMed ID: 8195841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of brodimoprim.
    Weidekamm E
    J Chemother; 1993 Dec; 5(6):475-9. PubMed ID: 8195840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacokinetics of azithromycin].
    Singlas E
    Pathol Biol (Paris); 1995 Jun; 43(6):505-11. PubMed ID: 8539072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
    Abernethy DR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E
    Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin.
    Lefèvre G; Duval M; Gauron S; Brookman LJ; Rolan PE; Morris TM; Piraino AJ; Morgan JM; Palmisano M; Close P
    Clin Pharmacol Ther; 1997 Jul; 62(1):50-9. PubMed ID: 9246019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isepamicin.
    Barr WH; Colucci R; Radwanski E; Zampaglione N; Cutler D; Lin CC; Elliott M; Affrime MB
    J Chemother; 1995 Jun; 7 Suppl 2():53-61. PubMed ID: 8622111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and blister fluid penetration of brodimoprim in adults.
    Novelli A; Mazzei T; Meli E; Cassetta MI; Fallani S; Periti P
    J Chemother; 1993 Dec; 5(6):494-8. PubMed ID: 8195844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age on the pharmacokinetics of butorphanol.
    Ramsey R; Higbee M; Maesner J; Wood J
    Acute Care; 1988; 12 Suppl 1():8-16. PubMed ID: 3344601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging effects on the organic base transporter and stereoselective renal clearance.
    Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
    Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
    Periclou A; Ventura D; Rao N; Abramowitz W
    Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
    Spotti D; Biffi M; Coppi G; Silingardi S; Mailland F
    Arzneimittelforschung; 1994 Dec; 44(12A):1470-2. PubMed ID: 7857344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Lidaprim in cases of impaired renal function.
    Hitzenberger G; Korn A; Pichler H; Bonelli J; Magometschnigg D
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):310-4. PubMed ID: 892947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of brodimoprim and cephalexin in the treatment of patients with acute sinusitis in general practice.
    Bockmeyer M; Riebenfeld D; Clasen B
    Clin Ther; 1994; 16(4):653-61. PubMed ID: 7982253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective disposition of ibuprofen in patients with renal dysfunction.
    Chen CY; Chen CS
    J Pharmacol Exp Ther; 1994 Feb; 268(2):590-4. PubMed ID: 8113969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).
    Roberts RK; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1978 Sep; 75(3):479-85. PubMed ID: 680505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.